Nepal | September 30, 2020

90% of China’s Sinovac employees, families took coronavirus vaccine: CEO

Reuters
Share Now:

BEIJING: About 90% of Sinovac Biotech Ltd employees and their families have taken an experimental coronavirus vaccine developed by the Chinese firm under the country’s emergency use programme, its chief executive said on Sunday.

The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to how actively it is using experimental vaccines in the hopes of protecting essential workers against a potential COVID-19 resurgence, even as trials are still underway.

The programme is intended for specific groups, including medical staffers and those who work at food markets and in the transportation and service sectors.

Sinovac, whose CoronaVac is in Phase 3 clinical trials and has been included in the emergency scheme, offered the candidate vaccine to approximately 2,000 to 3,000 employees and their families on a voluntary basis, CEO Yin Weidong told Reuters.

“As a vaccine developer and manufacturer, a new outbreak could directly impact our vaccine production,” Yin said on the sidelines of an international trade fair in Beijing, explaining why his company was included in the emergency programme.

Data gathered from the programme could offer evidence of the vaccine’s safety, but such data, which is not part of the registered clinical trial protocols, will not be used as main materials that regulators review in judging whether to approve the vaccine for commercial use, Yin said.

He said those who chose to be inoculated, including his wife and parents, had been informed of the potential side effects prior to taking the shot, and that its vaccine completing only early and mid-stage trials.

Yin, who also took the shot, said doctors asked about their health conditions before the vaccination, and the occurrence rate of adverse reaction among those vaccinated has been “very low”.

Side effects after taking CoronaVac include fatigue, fever and pain, with mostly mild symptoms, according to results of a mid-stage trial sponsored by Sinovac, involving 600 participants and published last month ahead of peer review. https://bit.ly/2GwIz9b

No vaccine has passed final, large-scale trials to prove it is effective and safe enough to protect people against the virus that has led to over 870,000 deaths globally.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Two more Covid-19 related fatalities reported in Banke

RANJHA: Two more Covid-19 related deaths have been reported in Banke district on Tuesday. According to Naresh Shrestha, corona resource person at District Health Office, Banke, a 41-year-old man of Ranitalau in Nepalgunj Sub-Metropolitan City-7, and a 53-year-old man of Kohalpur Municipality-10 Read More...

Nepal's coronavirus cases top 75,000 on Tuesday with 1513 infections

KATHMANDU: Nepal’s coronavirus tally moved to 76,258 as 1,513 new infections were reported in the last 24 hours. Read Also: Kathmandu valley registers record-high 934 single-day coronavirus cases As many as 731 people that had earlier contracted Covid-19 tested negative for the infection as Read More...

Ten Covid-19 fatalities recorded, death-toll inches closer closer to 500

KATHMANDU: Ten people passed away from Covid-19 related complications in the last 24 hours, with which the nationwide death-toll has moved to 491. Three women and seven men lost their lives due to this infection, the Health Ministry’s latest update showed. Read Also: Kathmandu valley registe Read More...

Kathmandu valley registers record-high 934 single-day coronavirus cases

KATHMANDU: The number of single-day coronavirus infections detected in the three districts of Kathmandu valley exceeded 900 for the first time on Tuesday. As many as 934 cases surfaced in the valley in the last 24 hours, of which a majority 747 infections were registered in the capital alone. Read More...

Nepal to receive 25 mln Russian Covid-19 vaccine doses

KATHMANDU: Russia is set to supply 25 million doses of its potential Covid-19 vaccine to Nepal. The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund on Tuesday said that it will supply the Russian Sputnik V vaccine through Trinity Pharmaceuticals based in Nepal. The pres Read More...

Liverpool's Klopp bristles at Keane's "sloppy" criticism

LONDON: Liverpool manager Juergen Klopp hit back at television pundit and former Manchester United captain Roy Keane on Monday after the Irishman described the Premier League champions' defending in a 3-1 win over Arsenal on Monday as "sloppy". Liverpool have won all three of their league games s Read More...

Djokovic seeks French Open redemption after New York fiasco

PARIS: Three weeks after an acrimonious exit at the US Open, world number one Novak Djokovic will resume his pursuit of an 18th Grand Slam title when he takes on Sweden's Mikael Ymer in the first round at the French Open on Tuesday. The Serbian had started as a heavy favourite to win the title at Read More...

Youth held for raping minor in Rautahat

RAUTAHAT: A youth has been arrested on the charges of raping a 15-year-old girl in Rauthat, on Monday night. The victim's father filed a first incident report (FIR) against 35-year-old Indal Das at a nearby police station. Subsequently, the accused was apprehended from his house around mid-night Read More...